128 related articles for article (PubMed ID: 38660888)
1. Rituximab treatment in resistant lupus nephritis: A single-center prospective study.
Alam S; Mazumder MA; Sharma M; Mahanta PJ; Parry MA; Doley PK
Clin Nephrol; 2024 Jul; 102():1-7. PubMed ID: 38660888
[TBL] [Abstract][Full Text] [Related]
2. Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis.
Davies RJ; Sangle SR; Jordan NP; Aslam L; Lewis MJ; Wedgwood R; D'Cruz DP
Lupus; 2013 May; 22(6):574-82. PubMed ID: 23632989
[TBL] [Abstract][Full Text] [Related]
3. Rituximab use as induction therapy for lupus nephritis: a systematic review.
Stolyar L; Lahita RG; Panush RS
Lupus; 2020 Jul; 29(8):892-912. PubMed ID: 32486934
[TBL] [Abstract][Full Text] [Related]
4. Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.
Condon MB; Ashby D; Pepper RJ; Cook HT; Levy JB; Griffith M; Cairns TD; Lightstone L
Ann Rheum Dis; 2013 Aug; 72(8):1280-6. PubMed ID: 23740227
[TBL] [Abstract][Full Text] [Related]
5. Rituximab as add-on therapy in patients with resistant lupus nephritis who have failed induction or maintenance therapy with other agents: A real-world experience from a single center in Mumbai.
Yadav S; Balakrishnan C; Mangat G; Kothari J
Lupus; 2024 Jan; 33(1):88-95. PubMed ID: 38048588
[TBL] [Abstract][Full Text] [Related]
6. Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study.
Boletis JN; Marinaki S; Skalioti C; Lionaki SS; Iniotaki A; Sfikakis PP
Nephrol Dial Transplant; 2009 Jul; 24(7):2157-60. PubMed ID: 19179411
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis.
Gunnarsson I; Sundelin B; Jónsdóttir T; Jacobson SH; Henriksson EW; van Vollenhoven RF
Arthritis Rheum; 2007 Apr; 56(4):1263-72. PubMed ID: 17393458
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy.
Tanaka Y; Takeuchi T; Miyasaka N; Sumida T; Mimori T; Koike T; Endo K; Mashino N; Yamamoto K
Mod Rheumatol; 2016; 26(1):80-6. PubMed ID: 26054418
[TBL] [Abstract][Full Text] [Related]
9. Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis.
Atisha-Fregoso Y; Malkiel S; Harris KM; Byron M; Ding L; Kanaparthi S; Barry WT; Gao W; Ryker K; Tosta P; Askanase AD; Boackle SA; Chatham WW; Kamen DL; Karp DR; Kirou KA; Sam Lim S; Marder B; McMahon M; Parikh SV; Pendergraft WF; Podoll AS; Saxena A; Wofsy D; Diamond B; Smilek DE; Aranow C; Dall'Era M
Arthritis Rheumatol; 2021 Jan; 73(1):121-131. PubMed ID: 32755035
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of bortezomib in refractory lupus nephritis: a single-center experience.
Segarra A; Arredondo KV; Jaramillo J; Jatem E; Salcedo MT; Agraz I; Ramos N; Carnicer C; Valtierra N; Ostos E
Lupus; 2020 Feb; 29(2):118-125. PubMed ID: 31865857
[TBL] [Abstract][Full Text] [Related]
11. Cyclophosphamide Versus Mycophenolate Versus Rituximab in Lupus Nephritis Remission Induction: A Historical Head-to-Head Comparative Study.
Goswami RP; Sircar G; Sit H; Ghosh A; Ghosh P
J Clin Rheumatol; 2019 Jan; 25(1):28-35. PubMed ID: 29561474
[TBL] [Abstract][Full Text] [Related]
12. Treatment outcomes in refractory lupus nephritis: Data from an observational study.
Gururani S; Devarasetti PK; Uppin M; Rajasekhar L
Lupus; 2021 Oct; 30(11):1725-1731. PubMed ID: 34304627
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts.
Díaz-Lagares C; Croca S; Sangle S; Vital EM; Catapano F; Martínez-Berriotxoa A; García-Hernández F; Callejas-Rubio JL; Rascón J; D'Cruz D; Jayne D; Ruiz-Irastorza G; Emery P; Isenberg D; Ramos-Casals M; Khamashta MA;
Autoimmun Rev; 2012 Mar; 11(5):357-64. PubMed ID: 22032879
[TBL] [Abstract][Full Text] [Related]
14. Rituximab alone as induction therapy for membranous lupus nephritis: A multicenter retrospective study.
Chavarot N; Verhelst D; Pardon A; Caudwell V; Mercadal L; Sacchi A; Leonardi C; Le Guern V; Karras A; Daugas E;
Medicine (Baltimore); 2017 Jul; 96(27):e7429. PubMed ID: 28682905
[TBL] [Abstract][Full Text] [Related]
15. Management practice and treatment outcomes of adult patients with Lupus Nephritis at the Renal Clinic of St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Hailu GT; Hussen SU; Getachew S; Berha AB
BMC Nephrol; 2022 Jun; 23(1):214. PubMed ID: 35715762
[TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis of nephritis response and renal outcome in a cohort of 928 Egyptian lupus nephritis patients: a university hospital experience.
Momtaz M; Fayed A; Wadie M; Gamal SM; Ghoniem SA; Sobhy N; Kamal Elden NM; Hamza WM
Lupus; 2017 Dec; 26(14):1564-1570. PubMed ID: 28625079
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.
Prasad N; Kurian J; Agarwal V; Bhadauria D; Behera M; Yacha M; Kushwaha R; Agrawal V; Jain M; Gupta A
Lupus; 2020 Jul; 29(8):845-853. PubMed ID: 32437258
[TBL] [Abstract][Full Text] [Related]
18. Single-dose rituximab in refractory lupus nephritis.
Kotagiri P; Martin A; Hughes P; Becker G; Nicholls K
Intern Med J; 2016 Aug; 46(8):899-901. PubMed ID: 27242250
[TBL] [Abstract][Full Text] [Related]
19. Long-term renal survival of paediatric patients with lupus nephritis.
Demir S; Gülhan B; Özen S; Çeleğen K; Batu ED; Taş N; Orhan D; Bilginer Y; Düzova A; Ozaltin F; Topaloğlu R
Nephrol Dial Transplant; 2022 May; 37(6):1069-1077. PubMed ID: 33826705
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of rituximab in comparison with common induction therapies in pediatric active lupus nephritis.
Basu B; Roy B; Babu BG
Pediatr Nephrol; 2017 Jun; 32(6):1013-1021. PubMed ID: 28191596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
